Welcome to our dedicated page for Nexgel Wt Exp 120126 SEC filings (Ticker: NXGLW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
NexGel, Inc. filings document an operating company built around high-water-content hydrogel products for healthcare, consumer, diagnostic, drug-delivery and cosmetic applications. Its SEC records include current reports on material definitive agreements, asset purchase and exclusive license arrangements, contract-manufacturing-related agreements, and amendments affecting consideration and assumed obligations.
The company’s filings also cover capital-structure matters such as convertible promissory notes and private-placement financing, governance disclosures including executive appointments and employment arrangements, and Nasdaq continued-listing compliance notices. These records provide formal disclosure on NexGel’s operating agreements, securities terms, board and management changes, and public-company reporting obligations.
NexGel, Inc. reported that board member Nachum Stein has notified the company of his intent to resign from its Board of Directors, effective February 2, 2026. He currently serves as Chairperson of the Board’s Compensation Committee and is leaving to lighten his schedule and focus on other business ventures.
The company states that Mr. Stein’s resignation is not due to any disagreement with NexGel or its subsidiaries on operations, policies, or practices. His resignation letter dated January 29, 2026 is included as Exhibit 17.1 to this report.
NexGel, Inc. reported that board member Nachum Stein has notified the company of his intent to resign from its Board of Directors, effective February 2, 2026. He currently serves as Chairperson of the Board’s Compensation Committee and is leaving to lighten his schedule and focus on other business ventures.
The company states that Mr. Stein’s resignation is not due to any disagreement with NexGel or its subsidiaries on operations, policies, or practices. His resignation letter dated January 29, 2026 is included as Exhibit 17.1 to this report.
Adam R. Levy, Chief Executive Officer and a director of NexGel, Inc. (NXGL), reported a sale of 4,000 shares of common stock on 08/28/2025 at a weighted average price of $2.4741 per share. The filing states the sale was made for tax planning purposes. After the transaction, Mr. Levy beneficially owned 358,284 shares. The shares sold were originally acquired from the issuer on October 15, 2019. The report commits to provide specific per-price share counts if requested by the SEC, the issuer, or a security holder.
Form 144 notice for NexGel, Inc. (NXGLW) reports a proposed sale of 4,000 common shares through Charles Schwab with an aggregate market value of $9,800, scheduled approximately for 08/28/2025. The filing states the company has 8,067,580 shares outstanding, and the shares to be sold were acquired on 10/15/2019 via founder shares, a PIPE, ESOP and open market purchases.
The filer also discloses recent sales by the same person totaling 8,000 shares across five transactions from 05/30/2025 to 06/11/2025 with gross proceeds ranging from $2,218 to $4,779. The notice includes the required representation that the seller has no undisclosed material adverse information and a signature/attestation section. Several standard filer fields (CIK, contact details) are not populated in the provided text.
NexGel reported consolidated revenue of $2.884 million for the quarter ended June 30, 2025, up from $1.440 million a year earlier, and $5.690 million for the six months versus $2.706 million in 2024. Growth was driven largely by its consumer branded products, which produced $1.884 million in the quarter (vs. $968 thousand) and $3.666 million for six months (vs. $1.585 million).
Despite revenue gains, NexGel remains unprofitable: net loss attributable to NexGel stockholders was $1.377 million for the six months and the company used $807 thousand in operating cash over the period. Cash on hand was $725 thousand at June 30, 2025 and working capital was about $1.8 million, which the company says raises substantial doubt about its ability to continue as a going concern. Management is pursuing expanded sales channels, product development and possible financing to address liquidity needs.
NexGel, Inc. furnished a press release reporting the Companys results for the quarter ended June 30, 2025, attached as Exhibit 99.1, and disclosed a new investor presentation attached as Exhibit 99.2.
The filing states these materials are being furnished (not "filed") for purposes of the Exchange Act and therefore are not automatically incorporated by reference into other securities filings. The cover information lists the Companys common stock and warrants trading on The Nasdaq Capital Market under the symbols NXGL and NXGLW, and indicates the Company is an emerging growth company.